THNR’s Weight-Loss Index Swaps Hims & Hers for Gilead
The Amplify Weight Loss Drug & Treatment ETF (THNR) just refreshed its holdings to keep pace with where the weight-loss drug race is heading. Its underlying index, the VettaFi Weight Loss Drug & Treatment Index (THINR), completed a scheduled rebalance on Sept. 18. Key Takeaways: THNR’s index dropped Scholar Rock and Hims & Hers for [...]
The post THNR’s Weight-Loss Index Swaps Hims & Hers for Gilead appeared first on ETF Trends .